Abstract:Background: As a common disabling disease, irreversible neuronal death due to spinal cord injury (SCI) is the root cause of functional impairment; however, the capacity for neuronal regeneration in the developing spinal cord tissue is limited. Therefore, there is an urgent need to investigate how defective neurons can be replenished and functionally integrated by neural regeneration; the reprogramming of intrinsic cells into functional neurons may represent an ideal solution. Methods: A mouse model of transection SCI was prepared by forceps clamping, and an adeno-associated virus (AAV) carrying the transcription factors NeuroD1 and Neurogenin-2(Ngn2) was injected in situ into the spinal cord to specifically overexpress these transcription factors in astrocytes close to the injury site. 5-bromo-2´-deoxyuridine (BrdU) was subsequently injected intraperitoneally to continuously track cell regeneration, neuroblasts and immature neurons marker expression, neuronal regeneration, and glial scar regeneration. In addition, immunoprotein blotting was used to measure the levels of transforming growth factor-β (TGF-β) pathway-related protein expression. We also evaluated motor function, sensory function, and the integrity of the blood-spinal cord barrier(BSCB). Results: The in situ overexpression of NeuroD1 and Ngn2 in the spinal cord was achieved by specific AAV vectors. This intervention led to a significant increase in cell regeneration and the proportion of cells with neuroblasts and immature neurons cell properties at the injury site(p < 0.0001). Immunofluorescence staining identified astrocytes with neuroblasts and immature neurons cell properties at the site of injury while neuronal marker-specific staining revealed an increased number of mature astrocytes at the injury site. Behavioral assessments showed that the intervention did not improve The BMS (Basso mouse scale) score (p = 0.0726) and gait (p > 0.05), although the treated mice had more sensory sensitivity and greater voluntary motor ability in open field than the non-intervention mice. We observed significant repair of the BSCB at the center of the injury site (p < 0.0001) and a significant improvement in glial scar proliferation. Electrophysiological assessments revealed a significant improvement in spinal nerve conduction (p < 0.0001) while immunostaining revealed that the levels of TGF-β protein at the site of injury in the intervention group were lower than control group (p = 0.0034); in addition, P70 s6 and PP2A related to the TGF-β pathway showed ascending trend (p = 0.0036, p = 0.0152 respectively). Conclusions: The in situ overexpression of NeuroD1 and Ngn2 in the spinal cord after spinal cord injury can reprogram astrocytes into neurons and significantly enhance cell regeneration at the injury site. The reprogramming of astrocytes can lead to tissue repair, thus improving the reduced threshold and increasing voluntary movements. This strategy can also improve the integrity of the blood-spinal cord barrier and enhance nerve conduction function. However, the simple reprogramming of astrocytes cannot lead to significant improvements in the striding function of the lower limbs.

179 Stem Progenitor Cell Proliferation in the Brainstem After Spinal Cord Injury: A Potential Target for Therapeutic Intervention Distant From the Site of Injury

Early Response of Endogenous Adult Neural Progenitor Cells to Acute Spinal Cord Injury in Mice

Thrombospondin-1 Modified Bone Marrow Mesenchymal Stem Cells (bmscs) Promote Neurite Outgrowth and Functional Recovery in Rats with Spinal Cord Injury.

250 Harnessing the Endogenous Stem Cell Response After Spinal Cord Injury: A Novel and Translationally Relevant Therapeutic Strategy

Stem Cell Transplantation: A Promising Therapy for Spinal Cord Injury.

Time-dependent changes in the microenvironment of injured spinal cord affects the therapeutic potential of neural stem cell transplantation for spinal cord injury

Widespread cellular proliferation and focal neurogenesis after traumatic brain injury in the rat

Neuronal repair after spinal cord injury by in vivo astrocyte reprogramming mediated by the overexpression of NeuroD1 and Neurogenin-2

Transplantation of Neural Progenitors and V2a Interneurons after Spinal Cord Injury

Engineering Microglial Cells to Promote Spinal Cord Injury Recovery

Recent advances in endogenous neural stem/progenitor cell manipulation for spinal cord injury repair

Temporal and spatial cellular and molecular pathological alterations with single-cell resolution in the adult spinal cord after injury

Cografted Wharton’s Jelly Cells-derived Neurospheres and BDNF Promote Functional Recovery after Rat Spinal Cord Transection

The Survival and Differentiation of Bone Marrow Stromal Cells after Spinal Cord Injury in Rat with Intravenous Administration

Transplantation of Neonatal Dorsal Root Ganglion Precursor Cells Promotes Remyelination and Functional Neurological Recovery after Spinal Cord Injury

Central Canal Ependymal Cells Proliferate Extensively in Response to Traumatic Spinal Cord Injury but Not Demyelinating Lesions

Bone Marrow Stromal Cells Promote Neuromotor Functional Recovery, Via Upregulation of Neurotrophic Factors and Synapse Proteins Following Traumatic Brain Injury in Rats.

Small molecules combined with collagen hydrogel direct neurogenesis and migration of neural stem cells after spinal cord injury

GR.6 Harnessing the endogenous regenerative potential of the injured spinal cord

survival and neurogenic potential of central canal-derived neural stem cells depend on spinal cord injury type

IFN-γ-STAT1-mediated CD8+ T-cell-neural stem cell cross talk controls astrogliogenesis after spinal cord injury